Zinzino AB (publ) management team changes
Zinzino AB (publ) are announcing a change of management at its Faun Pharma production unit. Former CEO, Erlend Strømnes hereby leaves the management team and company. The group's quality manager, Geir Smolan, will now take responsibility for the production unit as MD.
Geir Smolan holds a master's degree in chemistry and has extensive experience of working with management systems for quality, food safety and health and safety. He has also written a number of books covering these subjects. He joined Zinzino in 2014 as quality manager and he will now take over as MD of Faun Pharma.
‘’We would like to extend our thanks to Erlend for his time at Faun Pharma and the considerable contribution he has made to the company in recent years. We now face new challenges and welcome Geir Smolan. With his extensive knowledge of quality and management systems, we are convinced he will play an important part in our continued profitable growth," says Dag Bergheim Pettersen, CEO Zinzino AB (publ).
The management group (excluding Geir Smolan) is now made up of: CEO, Dag Bergheim Pettersen; CMO/CIO, Lars Dahlberg; Product Manager, Henrik Schultz; Logistics Manager, Helena Byström; COO USA, Michael Perry; R&D, Director Linda Saga; CFO, Fredrik Nielsen; Business Development/CCO, Jakob Spijker.
For more information:
Geir Smolan, MD, Faun Pharma, Tel. +47 93 28 88 95
Dag Bergheim Pettersen, CEO Zinzino AB (publ), Tel. +47 93 22 57 00
www.zinzino.se
Pictures for publication free of charge: Marcus Tollbom, Tel. + 46 (0)70 190 03 12
Certified Adviser: Erik Penser, Bank Aktiebolag
Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the above contact person for publication at 09.00 on 27th of September 2017.
Zinzino Nordic AB (publ.) is a direct sales company that operates throughout Europe and North America. Zinzino markets and sells products in two product lines: Zinzino Health, with a focus on long-term health, and Zinzino Coffee, consisting of espresso machines, coffee and tea. Zinzino owns the Norwegian company BioActie Foods AS and the research and production unit Faun Pharma AS. Zinzino has more than 120 employees and currently trades in 33 markets across Europe and North America. Zinzino is based in Gothenburg, with additional offices in Helsinki, Riga, and in Florida, USA. Zinzino is a public company and its shares are listed on Nasdaq First North. In 2016, Zinzino was recognized with the award ‘’Superföretag 2015’’ by Veckans Affärer and the ‘’Gazelle’’ award by Dagens Industri.
Tags: